vimarsana.com

Page 9 - ஐரோப்பிய சங்கம் ஆஃப் சிறுநீரகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Monitoring proves better than active treatment for low-risk prostate cancer

 E-Mail Men over 60 with low-risk prostate cancer could spend ten years with no active treatment, have a better sex life as a result, yet still be very unlikely to die from the disease, new research has found. The findings come from two new studies looking at active surveillance of prostate cancer - when the disease is closely monitored but not treated - presented at the European Association of Urology congress, EAU21, today. The first uses data from Sweden s National Prostate Cancer Register, which has information on virtually every man diagnosed with the disease in that country since 1998 - 23,649 of whom went on active surveillance.

EAU 2021: KEYNOTE-564: Phase 3 Trial of Pembrolizumab in the Adjuvant Treatment of Renal Cell Carcinoma Discussion

EAU 2021: KEYNOTE-564: Phase 3 Trial of Pembrolizumab in the Adjuvant Treatment of Renal Cell Carcinoma Discussion
urotoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from urotoday.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.